抗血管內皮生長因子單克隆抗體Bevacizumab玻璃體腔注射治療高度近視脈絡膜新生血管的療效觀察_Chinese Journal of Ocular Fundus Diseases

Chinese Journal of Ocular Fundus Diseases

Supervisor：China Association for Science and Technology Sponsor：Chinese Medical Association
Editor-in-chief：Li Xiaoxin
Publishing period： Monthly ISSN：1005-1015 CN：51-1434/R

抗血管內皮生長因子單克隆抗體Bevacizumab玻璃體腔注射治療高度近視脈絡膜新生血管的療效觀察

Chinese Journal of Ocular Fundus Diseases | 2008, 24(3): 218-219
First online：

Article Views：3519
PDF Downloads：420
Cited by：0

Authors：

Hong Yin Xiaoxin Li

Department of Ophthalmology, People′;
s Hospital of Peking University;

Corresponding?author：

Keywords：

脈絡膜新生血管化/藥物療法; 近視; 退行性/藥物療法; 抗體; 單克隆/治療應用; Bevacizumab

Video：

Export PDF Favorites Scan Get Citation

Abstract Full text Figures/Tables Video References Cited by

Citation： Hong Yin Xiaoxin Li. 抗血管內皮生長因子單克隆抗體Bevacizumab玻璃體腔注射治療高度近視脈絡膜新生血管的療效觀察. Chinese Journal of Ocular Fundus Diseases, 2008, 24(3): 218-219. doi: Copy

Chinese Journal of Ocular Fundus Diseases

抗血管內皮生長因子單克隆抗體Bevacizumab玻璃體腔注射治療高度近視脈絡膜新生血管的療效觀察

Abstract Full text Figures/Tables Video References Cited by

Format

Content